Department of Thyroid Surgery, The First Affiliated Hospital of Kunming Medical University, No. 295, Xichang Road, Kunming, 650032, Yunnan, China.
Sci Rep. 2023 Jul 5;13(1):10848. doi: 10.1038/s41598-023-37932-1.
The objective of this study was to investigate the expression of thyroid peroxidase (TPO) in papillary thyroid carcinoma (PTC) and to preliminarily investigate its value as a marker of lymph node metastasis and recurrence in patients with PTC. Clinical data of PTC patients and TPO expression were collected from The Cancer Genome Atlas (TCGA) database for analysis. We recruited 230 consecutive PTC patients from the Department of Thyroid Surgery of the First Affiliated Hospital of Kunming Medical University, collected their clinicopathological data, and also performed immunohistochemical analysis of TPO expression on their thyroid specimens to validate the results of bioinformatics analysis. In addition, the construction of protein-protein interaction networks was performed too. Functional enrichment analysis and immuno-infiltration analysis characterized the pathways in which TPO genes may be involved. Data mining based on the TCGA database showed that TPO expression in PTC tissues was significantly lower than in paired normal thyroid tissues. The expression level of TPO in PTC tissues correlated with tumor lymph node metastasis and recurrence. Follow-up data from our center also validated the difference in TPO expression and its relationship with lymph node metastasis in PTC patients. Functional enrichment analysis showed that TPO function was significantly associated with signaling pathways related to amino acid metabolism, gene expression regulation and tumorigenesis. TPO expression was also significantly associated with immune infiltration. Our study showed that reduced TPO expression was significantly associated with lymph node metastasis and recurrence in patients with PTC, and we validated this result in our central cohort. These data suggest that TPO may serve as a prognostic indicator for PTC.
本研究旨在探讨甲状腺过氧化物酶(TPO)在甲状腺乳头状癌(PTC)中的表达,并初步探讨其作为 PTC 患者淋巴结转移和复发标志物的价值。从癌症基因组图谱(TCGA)数据库中收集 PTC 患者的临床数据和 TPO 表达情况进行分析。我们从昆明医科大学第一附属医院甲状腺外科招募了 230 例连续的 PTC 患者,收集了他们的临床病理数据,并对其甲状腺标本进行 TPO 表达的免疫组织化学分析,以验证生物信息学分析的结果。此外,还构建了蛋白质-蛋白质相互作用网络。功能富集分析和免疫浸润分析描述了 TPO 基因可能涉及的途径。基于 TCGA 数据库的数据挖掘表明,PTC 组织中的 TPO 表达明显低于配对的正常甲状腺组织。PTC 组织中 TPO 的表达水平与肿瘤淋巴结转移和复发相关。我们中心的随访数据也验证了 PTC 患者 TPO 表达及其与淋巴结转移的差异。功能富集分析表明,TPO 功能与氨基酸代谢、基因表达调控和肿瘤发生相关的信号通路显著相关。TPO 表达也与免疫浸润显著相关。我们的研究表明,TPO 表达降低与 PTC 患者的淋巴结转移和复发显著相关,我们在中心队列中验证了这一结果。这些数据表明,TPO 可能作为 PTC 的预后指标。